International Journal of Biometeorology

, Volume 59, Issue 9, pp 1333–1343 | Cite as

One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial

  • A. FioravantiEmail author
  • G. Bacaro
  • C. Giannitti
  • S. Tenti
  • S. Cheleschi
  • G. M. Gui\delli
  • N. A. Pascarelli
  • M. Galeazzi
Original Paper


The objective of this prospective parallel randomized single-blind study was to assess that a cycle of mud-bath therapy (MBT) provides any benefits over usual treatment in patients with bilateral knee osteoarthritis (OA). Patients with symptomatic primary bilateral knee OA, according to ACR criteria, were included in the study and randomized to one of two groups: one group received a cycle of MBT at spa center of Chianciano Terme (Italy) in addition to the usual treatment, and one group continued their regular care routine alone. Clinical assessments were performed 7 days before enrollment (screening visit), at the time of enrollment (basal time), after 2 weeks, and after 3, 6, 9, and 12 months after the beginning of the study. All assessments were conducted by two researchers blinded to treatment allocation. The primary efficacy outcomes were the global pain score evaluated by Visual Analog Scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) subscore for physical function (W-TPFS). Of the 235 patients screened, 103 met the inclusion criteria: 53 patients were included in the MBT group and 50 in the control group. In the group of patients treated with MBT, we observed a statistically significant (p < 0.001) reduction of VAS and W-TPFS score at the end of the treatment; this improvement was significant (p < 0.05) also at 3 months of follow-up. The control group did not show significant differences between baseline time and all other times. The differences between one group were significant for both primary parameters already from the 15th day and persisted up to the 9th month. This beneficial effect was confirmed by the significant reduction of symptomatic drug consumption. Tolerability of MBT seemed to be good, with light and transitory side effects. Our results confirm that a cycle of MBT added to usual treatment provides a beneficial effect on the painful symptoms and functional capacities in patients with knee OA that lasts over time. Mud-bath therapy can represent a useful backup to pharmacologic treatment of knee OA or a valid alternative for patients who do not tolerate pharmacological treatments.


Osteoarthritis Knee Mud-bath therapy Randomized clinical trial 


Conflict of interest



This study was funded by Regione Toscana. This study sponsors did not participate in the study design, in the collection, analysis, or the interpretation of data.


  1. Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee diagnostic and therapeutic criteria committee of the american rheumatism association. Arthritis Rheum 29:1039–1049CrossRefGoogle Scholar
  2. Apolone G, Mosconi P (1998) The Italian SF-36 health survey: translation, validation and norming. J Clin Epidemiol 51:1025–1036CrossRefGoogle Scholar
  3. Arden N, Nevitt MC (2006) Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol 20:3–25CrossRefGoogle Scholar
  4. Ardic F, Ozgen M, Aybek H, Rota S, Cubukçu D, Gökgöz A (2007) Effects of balneotherapy on serum IL-1, PGE2 and LTB4 levels in fibromyalgia patients. Rheumatol Int 27:441–446CrossRefGoogle Scholar
  5. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Müllner M (2005) Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172:1039–1043CrossRefGoogle Scholar
  6. Bellamy N (2009) WOMAC Osteoarthritis Index: user guide IX. Queensland: WOMACGoogle Scholar
  7. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1998) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840Google Scholar
  8. Bellometti S, Galzigna L (1998) Serum levels of a prostaglandin and a leukotriene after thermal mud pack therapy. J Investig Med 46:140–145Google Scholar
  9. Bellometti S, Giannini S, Sartori L, Crepaldi G (1997) Cytokine levels in osteoarthrosis patients undergoing mud bath therapy. Int J Clin Pharmacol Res 17:149–153Google Scholar
  10. Bellometti S, Galzigna L, Richelmi P, Gregotti C, Bertè F (2002) Both serum receptors of tumor necrosis factor are influenced by mud pack treatment in osteoarthrotic patients. Int J Tissue React 24:57–64Google Scholar
  11. Bellometti S, Richelmi P, Tassoni T, Bertè F (2005) Production of matrix metalloproteinases and their inhibitors in osteoarthritic patients undergoing mud bath therapy. Int J Clin Pharmacol Res 25:77–94Google Scholar
  12. Bender T, Karagülle Z, Bálint GP, Gutenbrunner C, Bálint PV, Sukenik S (2005) Hydrotherapy, balneotherapy, and spa treatment in pain management. Rheumatol Int 25:220–224CrossRefGoogle Scholar
  13. Bender T, Bariska J, Vághy R, Gomez R, Kovács I (2007) Effect of balneotherapy on the antioxidant system—a controlled pilot study. Arch Med Res 38:86–89CrossRefGoogle Scholar
  14. Benedetti S, Canino C, Tonti G et al (2010) Biomarkers of oxidation, inflammation and cartilage degradation in osteoarthritis patients undergoing sulfur-based spa therapies. Clin Biochem 43:973–978CrossRefGoogle Scholar
  15. Bjordal JM, Ljunggren AE, Klovning A, Slørdal L (2004) Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 329:1317CrossRefGoogle Scholar
  16. Braga PC, Sambataro G, Dal Sasso M, Culici M, Alfieri M, Nappi G (2008) Antioxidant effect of sulphurous thermal water on human neutrophil bursts: chemiluminescence evaluation. Respiration 75:193–201CrossRefGoogle Scholar
  17. Bresalier RS, Sandler RS, Quan H et al (2005) Adenomatous polyp prevention on Vioxx (APPROVe) trial investigators. N Engl J Med 352:1092–1102CrossRefGoogle Scholar
  18. Committee for Proprietary Medicinal Products (1998) Points to consider on clinical investigation of medicinal products used in the treatment of osteoarthritis. European Agency for the Evaluation of medicinal products (London 23 July 1998). CPMP/EWP/784/97Google Scholar
  19. Cozzi F, Lazzarin P, Todesco S, Cima L (1995) Hypothalamic-pituitary-adrenal axis dysregulation in healthy subjects undergoing mud-bath applications. Arthritis Rheum 38:724–726CrossRefGoogle Scholar
  20. Ekmekcioglu C, Strauss-Blasche G, Holzer F, Marktl W (2002) Effect of sulfur baths on antioxidative defense systems, peroxide concentrations and lipid levels in patients with degenerative osteoarthritis. Forsch Komplementarmed Klass Naturheilkd 9:216–220CrossRefGoogle Scholar
  21. EMEA. Committee for medicinal products for human use (CHMP).Guideline on the choice of the non-inferiority margin. Doc. Ref. EMEA/CPMP/EWP/ 2158/99, issued London July, 27 2005Google Scholar
  22. Fautrel B, Hilliquin P, Rozenberg S et al (2007) Impact of osteoarthritis: results of a nationwide survey of 10,000 patients consulting for OA. Joint Bone Spine 72:235–240CrossRefGoogle Scholar
  23. Fioravanti A, Valenti M, Altobelli E et al (2003) Clinical efficacy and cost-effectiveness evidence of spa therapy in osteoarthritis. The results of “Naiade” Italian Project. Panminerva Med 45:211–217Google Scholar
  24. Fioravanti A, Cantarini L, Guidelli GM, Galeazzi M (2011a) Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there. Rheumatol Int 31:1–8. doi: 10.1007/s00296-010-1628-6 CrossRefGoogle Scholar
  25. Fioravanti A, Cantarini L, Bacarelli MR, de Lalla A, Ceccatelli L, Blardi P (2011b) Effects of spa therapy on serum leptin and adiponectin levels in patients with knee osteoarthritis. Rheumatol Int 31:879–882. doi: 10.1007/s00296-010-1401-x CrossRefGoogle Scholar
  26. Fioravanti A, Giannitti C, Bellisai B, Iacoponi F, Galeazzi M (2012) Efficacy of balneotherapy on pain, function and quality of life in patients with osteoarthritis of the knee. Int J Biometeorol 56:583–590. doi: 10.1007/s00484-011-0447-0 CrossRefGoogle Scholar
  27. Forestier R, Desfour H, Tessier JM et al (2010) Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial. Ann Rheum Dis 69:660–665CrossRefGoogle Scholar
  28. Fraioli A, Serio A, Mennuni G et al (2011) A study on the efficacy of treatment with mud packs and baths with Sillene mineral water (Chianciano Spa Italy) in patients suffering from knee osteoarthritis. Rheumatol Int 31:1333–1340. doi: 10.1007/s00296-010-1475-5 CrossRefGoogle Scholar
  29. Gaál J, Varga J, Szekanecz Z, Kurkó J, Ficzere A, Bodolay E, Bender T (2008) Balneotherapy in elderly patients: effect on pain from degenerative knee and spine conditions and on quality of life. Isr Med Assoc J 10:365–369Google Scholar
  30. Ghersetich I, Freedman D, Lotti T (2000) Balneology today. J Eur Acad Dermatol Venereol 14:346–348CrossRefGoogle Scholar
  31. Guccione AA, Felson DT, Anderson JJ et al (1994) The effects of specific medical conditions on the functional limitations of elders in the Framingham study. Am J Publ Health 84:351–358CrossRefGoogle Scholar
  32. Güngen G, Ardic F, Fındıkoğlu G, Rota S (2012) The effect of mud pack therapy on serum YKL-40 and hsCRP levels in patients with knee osteoarthritis. Rheumatol Int 32:1235–1244CrossRefGoogle Scholar
  33. Hochberg MC, Altman RD, April KT et al (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64:465–474CrossRefGoogle Scholar
  34. Hurst NP, Jobanputra P, Hunter M, Lambert M, Lochhead A, Brown H (1994) Validity of Euroqol—a generic health status instrument—in patients with rheumatoid arthritis. Economic and health outcomes research group. Br J Rheumatol 33:655–662CrossRefGoogle Scholar
  35. Huskisson EC, Berry H, Gishen P, Jubb RW, Whitehead J (1995) Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group Longitudinal investigation of nonsteroidal antiinflammatory drugs in knee osteoarthritis. J Rheumatol 22:1941–1946Google Scholar
  36. Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126CrossRefGoogle Scholar
  37. Jordan KM, Arden NK, Doherty M et al (2003) Standing committee for international clinical studies including therapeutic trials ESCISIT. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 62:1145–1155CrossRefGoogle Scholar
  38. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332:1302–1308CrossRefGoogle Scholar
  39. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteoarthrosis. Ann Rheum Dis 16:494–502CrossRefGoogle Scholar
  40. Kersten P, White PJ, Tennant A (2010) The visual analogue WOMAC 3.0 scale-internal validity and responsiveness of the VAS version. BMC Musculoskelet Disord 11:80CrossRefGoogle Scholar
  41. Kubota K, Kurabayashi H, Tamura K, Kawada E, Tamura J, Shirakura T (1992) A transient rise in plasma beta-endorphin after a traditional 47 degrees C hot-spring bath in Kusatsu-spa, Japan. Life Sci 51:1877–1880CrossRefGoogle Scholar
  42. Kuczera M, Kokot F (1996) Effect of spa therapy on the endocrine system. I. Stress reaction hormones. Pol Arch Med Wewn 95:11–20Google Scholar
  43. Kulisch A, Benkö A, Bergmann A et al (2014) Evaluation of the effect of Lake Hévíz thermal mineral water in patients with osteoarthritis of the knee: a randomized, controlled, single-blind, follow-up study. Eur J Phys Rehabil Med 50:373–381Google Scholar
  44. McAlindon TE, Bannuru RR, Sullivan MC et al (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr Cartil 22:363–388CrossRefGoogle Scholar
  45. McConnell S, Kolopack P, Davis AM (2001) The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum 45:453–461CrossRefGoogle Scholar
  46. Melzack R, Wall PD (1965) Pain mechanism: a new theory. Science 150:971–979CrossRefGoogle Scholar
  47. Neame R, Zhang W, Doherty M (2004) A historic issue of the annals: three papers examine paracetamol in osteoarthritis. Ann Rheum Dis 63:897–900CrossRefGoogle Scholar
  48. Odabasi E, Turan M, Erdem H, Tekbas F (2008) Does mud pack treatment have any chemical effect? A randomized controlled clinical study. J Altern Complement Med 14:559–565. doi: 10.1089/acm.2008.0003 CrossRefGoogle Scholar
  49. Ofman JJ, MacLean CH, Straus WL et al (2002) A metaanalysis of severe upper gastrointestinal complications of nonsteroidal anti-inflammatory drugs. J Rheumatol 29:804–812Google Scholar
  50. R Development Core Team (2013). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN: 3-900051-07-0,
  51. Salaffi F, Leardini G, Canesi B et al (2003) Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthr Cartil 11:551–560CrossRefGoogle Scholar
  52. Sarsan A, Akkaya N, Ozgen M, Yildiz N, Atalay NS, Ardic F (2012) Comparing the efficacy of mature mud pack and hot pack treatments for knee osteoarthritis. J Back Musculoskelet Rehabil 25:193–199. doi: 10.3233/BMR-2012-0327 Google Scholar
  53. Schmidt KL (1995) Scientific basis of spa treatment in rheumatic diseases. Rheumatol Eur 24:136–140Google Scholar
  54. Shani J, Barak S, Levi D et al (1985) Skin penetration of minerals in psoriatics and guinea-pigs bathing in hypertonic salt solutions. Pharmacol Res Commun 17:501–512CrossRefGoogle Scholar
  55. Shehata M, Schwarzmeier JD, Hilgarth M et al (2006) Effect of combined spa-exercise therapy on circulating TGF-beta1 levels in patients with ankylosing spondylitis. Wien Klin Wochenschr 118:266–272CrossRefGoogle Scholar
  56. Sukenik S, Flusser D, Abu-Shakra M (1999) The role of spa therapy in various rheumatic diseases. Rheum Dis Clin North Am 25:883–897CrossRefGoogle Scholar
  57. Tefner IK, Gaál R, Koroknai A et al (2013) The effect of Neydharting mud-pack therapy on knee osteoarthritis: a randomized, controlled, double-blind follow-up pilot study. Rheumatol Int 33:2569–2576. doi: 10.1007/s00296-013-2776-2 CrossRefGoogle Scholar
  58. Verhagen AP, Bierma-Zeinstra SM, Boers M et al (2007) Balneotherapy for osteoarthritis. Cochrane Database Syst Rev 17, CD006864Google Scholar
  59. Ware J Jr, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233CrossRefGoogle Scholar
  60. WHO (1997). The world health report: 50 facts. Geneva: World Health Organization. Available from Accessed on February 18, 2014
  61. Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646–656Google Scholar

Copyright information

© ISB 2014

Authors and Affiliations

  • A. Fioravanti
    • 1
    Email author
  • G. Bacaro
    • 2
    • 3
  • C. Giannitti
    • 1
  • S. Tenti
    • 1
  • S. Cheleschi
    • 1
  • G. M. Gui\delli
    • 1
  • N. A. Pascarelli
    • 1
  • M. Galeazzi
    • 1
  1. 1.Rheumatology Unit, Department of Medicine, Surgery and NeurosciencesUniversity of SienaSienaItaly
  2. 2.CNR-IRPI, Istituto di Ricerca per la Protezione IdrogeologicaPerugiaItaly
  3. 3.BIOCONNET, Biodiversity and Conservation Network, Department of Life SciencesUniversity of SienaSienaItaly

Personalised recommendations